Biomaterials & Medical Products Commercialization SIG Update

摘要

The Biomaterials & Medical Products Commercialization Special Interest Group and its members exchange ideas and experiences regarding the translation,and subsequent commercialization,of medical products dependent upon biomaterials for utility and/or efficacy.Members include students,faculty,and industry representatives spanning numerous academic institutions,corporations,and regulatory entities.The BMPC SIG had an exciting and successful Annual Meeting and Exposition in Seattle,Washington earlier this year.In addition to hosting and co-hosting 6 sessions,including two panel discussions on technology translation and commercialization,the BMPC hosted the annual Business Plan Competition.Moderated by Elaine Duncan(President,Paladin Medical,Inc.)and Jim Curtis(DuPont),this competition featured 4 international teams(2 USA,1 Portugal,1 Canada)who presented their business plans for a technology concept related to biomaterials:1.Evoke Medical,LLC:P/ezoNa//-Stimulating a Pathway to Better Fracture Healing.Zachary R.Pessia,Craig A.Cunningham,Ember D.Krech,and E.A.Friis.University of Kansas.2.SAPHTx:Injectable Hydrogel for Treating Neovascular Ocular Diseases.Biplab Sarkar,Peter K.Nguyen,Zain Siddiqui,Vivek A.Kumar.New Jersey Institute of Technology.3.B-CULTURE.Raphael F.Canadas,Joaquim M.Oliveira,Alexandra P.Marques,and Rui L.Reis.University of Minho.4.HumeurVitree:Revolutionizing Retinal Detachment Surgery.Frances Lasowski,Ben Muirhead,and Heather Sheardown.McMaster University.